Iberogast (Milk Thistle Fruit Extract, Bitter Candytuft Fresh Plant Extract, Matricaria Liquid Extract, Menthae)

Iberogast contains several plant extracts that provide spasmolytic, anti‑inflammatory and pro‑kinetic effects. These compounds modulate smooth‑muscle activity, reduce inflammatory mediators and enhance gut motility through serotonergic and cholinergic pathways, supporting normal digestive function.

The appropriate dose of Iberogast is determined by a prescriber based on the individual’s condition, age and overall health. Patients should follow the dosing instructions provided by their healthcare professional and not adjust the dose on their own.

Safety of Iberogast in pregnancy and lactation has not been established. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks with their physician before using this product.

To order Iberogast, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with single‑ingredient antacids or pro‑kinetic drugs, Iberogast offers a multi‑targeted herbal approach that combines spasmolytic, anti‑inflammatory and motility‑enhancing actions. This broader mechanism may benefit patients with mixed gastrointestinal symptoms, though individual response can vary.

Iberogast should be stored at ambient temperature, below 25 °C, in its original packaging. Keep the bottle tightly closed, protect it from moisture and direct sunlight to maintain product stability.

Iberogast is supplied as liquid oral drops. The recommended method is to measure the prescribed number of drops with the provided dropper and swallow them directly or mix with a small amount of water, as advised by a healthcare professional.

Serious but rare risks include allergic reactions such as rash, urticaria or anaphylaxis, and potential liver enzyme elevations. Patients should seek immediate medical attention if they experience signs of a severe allergic response or persistent abdominal pain.

Iberogast should be avoided by individuals with known hypersensitivity to any of its botanical components, children unless specifically prescribed, and patients with severe liver disease without medical supervision. Pregnant or breastfeeding women should only use it after consulting a physician.